Schering-Plough Drops Garenoxacin NDA, But Leaves Door Open For Resubmission
This article was originally published in The Pink Sheet Daily
Executive Summary
Sept. 11 advisory committee meeting on antibiotic cancelled.
You may also be interested in...
Schering-Plough Pulls Garenoxacin Application In Europe
Action comes one year after the company withdrew an NDA for the antibiotic in the U.S.
Schering-Plough Pulls Garenoxacin Application In Europe
Action comes one year after the company withdrew an NDA for the antibiotic in the U.S.
Wyeth’s Desvenlafaxine Advisory Committee Is Cancelled
FDA determines that its questions have been satisfactorily answered.